• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pfizer, BioNTech Enter Vax Pact with COVAX

    FDA Approves Janssen’s CABENUVA

    AGC Biologics Appoints Boulder Site GM

    Lilly Completes $1B Acquisition of Prevail

    Top BioPharma Form Accumulus Synergy
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Integrated Continuous Manufacturing ICM

    CONTINUUS Awarded $69.3M DoD Grant

    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Lilly Completes $1B Acquisition of Prevail

    Top BioPharma Form Accumulus Synergy

    Coating Place Wurster Fluid Bed Process Scaling

    AbbVie Licenses ProBioGen’s GlymaxX Technology

    Improving Product Profitability
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    Aphena Pharma Solutions

    Emergent BioSolutions

    Cytovance Biologics

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Almac Group

    Emergent BioSolutions

    Aphena Pharma Solutions

    Reed-Lane

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Altimmune Adds Lonza as a Manufacturing Partner

    For supply of AdCOVID, its single-dose intranasal vaccine candidate for COVID-19.

    Related CONTENT
    • FDA Approves Janssen’s CABENUVA
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Biogen Licenses CEVEC AAV Mfg. Technology
    • Akston Biosciences and LakePharma Enter Covid-19 Partnership
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Contract Pharma Staff11.10.20
    Altimmune, Inc., a clinical-stage biopharmaceutical company, has entered into an agreement with Lonza for the manufacturing of AdCOVID, Altimmune’s next-generation single-dose intranasal vaccine candidate for COVID-19.
     
    AdCOVID is a single-dose COVID-19 vaccine candidate that has the potential to be conveniently administered via an intranasal spray. In addition to activating systemic immunity (neutralizing antibodies and T cell responses), AdCOVID stimulates a type of localized immunity called mucosal immunity, which can act to prevent both SARS-CoV-2 virus infection and transmission.
     
    In preclinical studies, AdCOVID produced a 29-fold increase in mucosal IgA, well above the level associated with protection observed in several clinical studies from influenza, another respiratory virus.
     
    Based on clinical experience with the Altimmune’s vaccine platform technology, AdCOVID is expected to provide durable immunity of up to a year or more following a single dose and to have an excellent tolerability and stability profile. Vaccine stability is critical for efficient vaccine deployment and AdCOVID is expected to be shipped without a cold chain and permit common refrigerated storage conditions at community-based vaccination centers without the need for specialized freezer storage.
     
    “We are excited about the potential of our AdCOVID vaccine candidate and are actively focused on expanding our network of strategic manufacturing partners to ensure Altimmune’s commercial readiness to supply vaccine in 2021 should our clinical data support this advancement,” said Vyjoo Krishnan, vice president of product development, Altimmune. “Lonza is a tremendous partner in this mission, with deep expertise and experience in vector manufacturing and global world-class facilities capable of manufacturing AdCOVID at commercial scale.”
     
    Vipin K. Garg, president and chief executive officer, Altimmune, said, “We strongly believe there is a compelling need for next-generation COVID-19 vaccines and are rapidly advancing our development program for AdCOVID to meet this demand. Our agreement with Lonza expands on our current clinical and commercial manufacturing strategy for AdCOVID, aligning us with leaders in vaccine manufacturing and positioning Altimmune for commercial-readiness in 2021.  We plan to commence a clinical study of AdCOVID in the fourth quarter, with a data readout from this study anticipated in the first quarter of 2021.”
     
    Alberto Santagostino, senior vice president, head of cell and gene technologies, Lonza, said, “We are deeply committed to fighting this global pandemic and deploying our expertise and resources to help vaccine developers like Altimmune meet commercial manufacturing requirements for novel and promising vaccine candidates. Lonza is proud to be well-positioned to support these companies in their mission to serve such critical public health needs.”
    Suggested For You
    FDA Approves Janssen’s CABENUVA  FDA Approves Janssen’s CABENUVA
    Grifols Begins COVID-19 Plasma Treatment Trial Grifols Begins COVID-19 Plasma Treatment Trial
    Biogen Licenses CEVEC AAV Mfg. Technology Biogen Licenses CEVEC AAV Mfg. Technology
    Akston Biosciences and LakePharma Enter Covid-19 Partnership Akston Biosciences and LakePharma Enter Covid-19 Partnership
    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021 The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    INOVIO to Develop dMAb COVID Treatments under DARPA Grant INOVIO to Develop dMAb COVID Treatments under DARPA Grant
    [VIRTUAL LAUNCH] Redefining Virus Manufacturing with NevoLine™ Upstream [VIRTUAL LAUNCH] Redefining Virus Manufacturing with NevoLine™ Upstream
    Life Sciences Strive for Greater Agility Life Sciences Strive for Greater Agility
    Navigating Uncertainty: Considerations for Life Sciences 2021 Navigating Uncertainty: Considerations for Life Sciences 2021
    Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies
    Gilead to Acquire MYR GmbH for €1.15B Gilead to Acquire MYR GmbH for €1.15B
    Lonza Capsules and Health Ingredients Lonza Capsules and Health Ingredients
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track  ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track

    Related Breaking News

    • Breaking News | Industry News
      Pfizer, BioNTech Enter Vax Pact with COVAX

      Pfizer, BioNTech Enter Vax Pact with COVAX

      Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.
      Kristin Brooks 01.22.21

    • Breaking News | Trials & Filings
      FDA Approves Janssen’s CABENUVA

      FDA Approves Janssen’s CABENUVA

      Becomes first and only once-monthly, long-acting regimen for the treatment of HIV infection.
      Kristin Brooks 01.22.21

    • Breaking News | Promotions & Moves
      AGC Biologics Appoints Boulder Site GM

      AGC Biologics Appoints Boulder Site GM

      David Stewart to oversee the startup, strategic development and operational excellence in large-scale biologics production at the Boulder, CO site.
      Kristin Brooks 01.22.21


    • Breaking News | Drug Development | Drug Discovery | Industry News
      Lilly Completes $1B Acquisition of Prevail

      Lilly Completes $1B Acquisition of Prevail

      Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.
      Kristin Brooks 01.22.21

    • Breaking News | Drug Development | Industry News | Information Technology | Regulatory Affairs
      Top BioPharma Form Accumulus Synergy

      Top BioPharma Form Accumulus Synergy

      Aims to develop a cloud-based Global Data Sharing Platform to facilitate data and information sharing between industry and health authorities worldwide.
      Kristin Brooks 01.22.21

    • Breaking News | cGMP Manufacture | Industry News
      CONTINUUS Awarded $69.3M DoD Grant

      CONTINUUS Awarded $69.3M DoD Grant

      Will enable construction of the country's first GMP facility for end-to-end, ICM-driven production of small-molecule drugs in Woburn, MA.
      Kristin Brooks 01.22.21


    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      AbbVie Licenses ProBioGen’s GlymaxX Technology

      AbbVie Licenses ProBioGen’s GlymaxX Technology

      Will apply GlymaxX technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).
      Kristin Brooks 01.22.21

    • Breaking News | Facilities | Industry News | Logistics | Packaging & Tracking
      WDSrx Expands Warehouse Network

      WDSrx Expands Warehouse Network

      Pharma logistics company creates national network with expansion to Reno, NV.
      Tim Wright, Editor, Contract Pharma 01.21.21

    • Aseptic Processing | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Fill/Finish | Industry News
      Piramal Inks Clinical Supply Deal with Theratechnologies

      Piramal Inks Clinical Supply Deal with Theratechnologies

      CDMO to provide sterile fill/finish drug product formulation and manufacturing from its Lexington, KY facility.
      Tim Wright, Editor, Contract Pharma 01.21.21


    • Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
      Recipharm Signs Manufacturing Deal with Enzymatica

      Recipharm Signs Manufacturing Deal with Enzymatica

      Agreement will involve an additional Recipharm production site in Pianezza, Italy.
      Tim Wright, Editor, Contract Pharma 01.21.21

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
      CDMO Northway Biotech Expands in U.S.

      CDMO Northway Biotech Expands in U.S.

      Opens new biopharmaceutical manufacturing site in greater Boston area.
      Tim Wright, Editor, Contract Pharma 01.21.21

    • Breaking News | Industry News | Information Technology | Validation
      Global Biosciences Co. Selects ValGenesis VLMS

      Global Biosciences Co. Selects ValGenesis VLMS

      Will digitize the validation service activities for efficient and faster access to validated and safer products across 40 countries.
      Contract Pharma Staff 01.20.21


    • Breaking News | Promotions & Moves
      Eisai Appoints Chief Clinical Officer of Oncology Biz

      Eisai Appoints Chief Clinical Officer of Oncology Biz

      Dr. Richard Woodman has 18 years of pharmaceutical experience in several different functional areas at both large and small biotech organizations.
      Contract Pharma Staff 01.20.21

    • Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Nexelis Acquires GSK Vax Lab in Marburg

      Nexelis Acquires GSK Vax Lab in Marburg

      Enters into a 5-year strategic agreement to support the development of future GSK vaccine candidates.
      Contract Pharma Staff 01.20.21

    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      Bone Therapeutics, Rigenerand Ink Cell Therapy Deal

      Bone Therapeutics, Rigenerand Ink Cell Therapy Deal

      Enter an agreement for a process development partnership.
      Contract Pharma Staff 01.19.21

    Trending
    • Integrated Continuous Manufacturing ICM
    • Pfizer, BioNTech Enter Vax Pact With COVAX
    • CONTINUUS Awarded $69.3M DoD Grant
    • Piramal Inks Clinical Supply Deal With Theratechnologies
    • AbbVie Licenses ProBioGen’s GlymaxX Technology
    Breaking News
    • Pfizer, BioNTech Enter Vax Pact with COVAX
    • FDA Approves Janssen’s CABENUVA
    • AGC Biologics Appoints Boulder Site GM
    • Lilly Completes $1B Acquisition of Prevail
    • Top BioPharma Form Accumulus Synergy
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    LINE-X Launches Dealer Program with International Truck
    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Carol’s Daughter Adds New Hair Products
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login